Back to search
Tricuspid Regurgitation (TR)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Tricuspid Regurgitation (TR) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Tricuspid Regurgitation (TR) trials you may qualify forHeart disease is the leading cause of death in the United States, and echocardiography (or "echo") is the most common way doctors look at the heart. Echo is saf…
Valvular heart disease (VHD), caused by abnormalities in heart valves, can lead to severe complications such as heart failure and death, with approximately 220…
The goal of this observational post approval study is to confirm the safety and efficacy of the TriClip System when used in routine clinical practice in the Jap…
This investigation is a continuation for "TARGET" investigation and its purpose is to further demonstrate the efficiency and safety of the Cardiovalve system in…
The goal of this clinical trial is to record the incidence of newly developed or worsening tricuspid valve regurgitation (TR) following the implantation of a pa…
The objective of this study is to evaluate the safety and performance of Cardiovalve TR system
Tricuspid regurgitation (TR) is a public health problem: moderate / severe TR are common, especially in ageing populations, and affect 4% of the population \>75…
Clinical Study of the Edwards Cardioband FIT Repair System
The purpose of the study is to evaluate safety and effectiveness of the TRiCares Topaz TTVR system for treatment of subjects presenting with clinically relevant…